Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1992-08-19
1994-10-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424485, 424486, 424450, A61K 914
Patent
active
053545613
DESCRIPTION:
BRIEF SUMMARY
The present invention relates to a process for the production of solid forms of active substances, to the products obtained with the aid of this process, and to the use of these products for the production of drugs.
It is known that phase separation occurs when an aqueous solution of polyethylene glycol and a likewise aqueous solution of dextran are mixed. According to U.S. Pat. No. 4,794,000, the lower "colloid-rich" phase can be employed for formulating active substances, where appropriate after the addition of other auxiliaries such as lecithin. All the formulations described therein are, however, liquid drug forms, often highly viscous, and therefore disadvantageous, especially for oral administration forms. In addition, there must be expected to be, especially in the liquid state, considerable stability problems of a physical (phase separation, recrystallization etc.) and chemical nature (hydrolysis reactions, oxidations etc.).
All the auxiliaries employed for the formulation (polyethylene glycol 6000, dextran 40 and egg lecithin) display wax-like, sticky properties and therefore give rise to problems in the formulation of active substances. In their turn, active substances may have a consistency which makes pharmaceutical processing difficult.
A very straightforward and efficient process for the production of solid forms of active substances has now been found.
The invention relates to a process for the production of solid forms of active substances, which forms have good redispersibility in aqueous systems, which comprises mixing PEG and dextran with water and--if phase separation occurs--removing the upper phase, dissolving an active substance in the mixture, where appropriate adding a physiologically tolerated amphiphile, and subsequently removing the water.
Particularly suitable active substances are those which are soluble in water. Suitable as PEG (=polyethylene glycol) are, in particular, those with a molecular weight of 2,000 to 20,000, e.g. PEG 4,000 and PEG 10,000. PEG 6,000 is very particularly suitable.
It is advisable to add an amphiphile to the mixture after adding the active substance. Suitable as amphiphile are all which are physiologically tolerated, such as lipids which form bilayer membranes. Examples of these are phospholipids or synthetic amphiphiles. Examples of synthetic amphiphiles are described in EP-A 331,092. Very particularly suitable are phospholipids, preferably lecithins such as egg lecithin, soybean lecithin and synthetic phospholipids.
The removal of the water from the substance mixture is carried out, for example, by spray-drying or freeze-drying.
The invention also relates to the active substance form which is obtained by the described process and which can be processed in a known manner to a finished drug form. The active substance form is very suitable for the production of instant forms, for example for injection preparations and for drinkable solutions, but also, furthermore, in particular for solid oral drug forms (after the powder has been packed into hard gelatin capsules or compressed to tablets).
It was surprising that defined mixtures of these sticky, wax-like auxiliaries yield, even in combination with various active substances after removal of the water, a hard, brittle and easily powdered composition which is free-flowing and therefore can, for example, be packed without problems into hard gelatin capsules. These product properties were not predictable because of the consistency of the starting materials. It was furthermore surprising that transparent films are formed on removal of the water when the solution is, for example, dried in a shallow dish. The films adhere extremely poorly to glass and become detached from the substrate without further treatment. This property was not predictable either, because of the consistency of the starting materials. The transparency of the films containing active substance suggests that the active substance is present in molecular disperse form, in the form of a quasi "solid solution".
The solid forms of active substa
REFERENCES:
patent: 4794000 (1988-12-01), Ecanow
patent: 4963367 (1990-10-01), Ecanow
patent: 4997867 (1991-03-01), Jederstrom
patent: 5147655 (1992-09-01), Ibsen
Heberger Juergen
Rosenberg Joerg
Benston, Jr. William E.
Knoll AG
Page Thurman K.
LandOfFree
Process for producing solid active substance forms and products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing solid active substance forms and products , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing solid active substance forms and products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1657078